GSK OTC Boycott Urged In Multi-State “Tums Down” Campaign
This article was originally published in The Tan Sheet
Executive Summary
Senior advocacy groups in more than 10 states across the country are urging consumers to boycott GlaxoSmithKline's OTC drug products through press events and postcards, e-mails and telephone calls to GSK and congressional leaders